Organigram Strengthens Leadership Team with Government Relations Expert
MCIG Names Victor Nuyen as COO
Aurora Cannabis Reports Earnings Tomorrow. Here’s What to Expect.
Cannabis Stock News Daily Roundup May 13
Hedge Funds Have Never Been More Bullish On Innovative Industrial Properties, Inc. (IIPR)
Students at the University of Calgary create an impairment-detecting headset
Is Aurora Cannabis' Partnering Strategy Brilliant or Boneheaded?
Better Marijuana Stock: HEXO vs. MariMed
Walmart earnings, retail sales – What to know in the week ahead
These 4 Pot Stocks Have Surprisingly Poor Crop Yields
Harlem Grown promotes healthy eating where '98% of our families are on food stamps'
Is Cronos Group a Buy on the Dip?
The Week In Cannabis: A&F Tries CBD, GW Pharma Soars On Results, Denver Decriminalizes Mushrooms
Writedowns Are Likely for These 3 Marijuana Stocks
Better Buy: Canopy Growth vs. Aphria
'Jeopardizing my children's lifestyle': Marijuana industry moms face a unique stigma
Arkansas’ first medical marijuana dispensary opens its doors
Better Marijuana Stock: Tilray vs. Village Farms
Health Canada Is Tackling the Marijuana Shortage With This Game-Changing Move
A Canadian Cannabis Firm Can’t Find Good Weed
Insys says it may be forced to file for bankruptcy due to litigation cash crunch
Insys Therapeutics (INSY) Reports Q1 Loss, Lags Revenue Estimates
Arena Pharmaceuticals Inc (ARNA) Q1 2019 Earnings Call Transcript
Insys Therapeutics: 1Q Earnings Snapshot
INSYS Therapeutics Reports First Quarter 2019 Results
Khiron Mails and Files Circular Relating to its Annual General and Special Meeting of Shareholders
Toronto Police Seize $17 Million in Drugs During Large-Scale Bust
Cramer's week ahead: The market can go higher with Uber's IPO, tariffs behind us
Davis-based Marrone doubles revenue with strong sales of bio-insecticides
The Cannabis ‘Magic Bus’ Is About to Depart the Station! Next Stops? Aurora Cannabis, Hexo, Canopy Growth and Aphria
Chuck Schumer, Hakeem Jeffries Reintroduce Bill to Federally Decriminalize Marijuana
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against KushCo Holdings, Inc.
3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm